Literature DB >> 9179626

Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis.

X Fan1, R P Wüthrich.   

Abstract

MRL-Fas(lpr) mice develop an aggressive form of autoimmunity, characterized by immune complex-mediated glomerulonephritis and massive expansion of lymphoid tissues. Increased MHC class II expression by macrophages and renal parenchymal cells is a prominent feature of MRL-Fas(lpr) mice. Since interferon-gamma (IFN-gamma) is the major and the most potent inducer of MHC class II molecules it could play a pathogenic role in the disease process in MRL-Fas(lpr). We have analyzed IFN-gamma expression in normal and nephritic MRL-Fas(lpr) mice by examining renal and lymphoid IFN-gamma-specific mRNA production, using reverse transcription-polymerase chain reaction (RT-PCR) and Northern blotting. We detect abundant IFN-gamma mRNA expression in the kidney of nephritic MRL-Fas(lpr) by RT-PCR, whereas normal mice display absent or only very weak expression of this cytokine. By RT-PCR, IFN-gamma mRNA is detectable in normal spleen, but is overexpressed in the enlarged spleen and lymph nodes of MRL-Fas(lpr). Northern blotting using total RNA from tissues confirms abundant IFN-gamma expression in spleen and lymph node of MRL-Fas(lpr). We conclude that enhanced renal IFN-gamma mRNA expression is a prominent feature of MRL-Fas(lpr) lupus nephritis. Increased IFN-gamma produced by infiltrating T cells could lead to increased MHC class II expression by renal parenchymal cells, thereby promoting the nephritic process by augmentation of antigen presentation in the kidney of autoimmune MRL-Fas(lpr).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179626     DOI: 10.1023/a:1027399027170

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  33 in total

Review 1.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

Review 2.  Cytokines and growth factors in renal disease.

Authors:  I L Noronha; Z Niemir; H Stein; R Waldherr
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

3.  Increase in macrophage Ia expression in autoimmune mice: role of the Ipr gene.

Authors:  V E Kelley; J B Roths
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

4.  Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.

Authors:  J M Boswell; M A Yui; D W Burt; V E Kelley
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

5.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

6.  Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis.

Authors:  R P Wuthrich; M A Yui; G Mazoujian; N Nabavi; L H Glimcher; V E Kelley
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

7.  Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms.

Authors:  H Yokoyama; B Kreft; V R Kelley
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

8.  Interferon gamma-mediated renal MHC expression in mercuric chloride-induced glomerulonephritis.

Authors:  J Madrenas; N A Parfrey; P F Halloran
Journal:  Kidney Int       Date:  1991-02       Impact factor: 10.612

9.  Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.

Authors:  J M Boswell; M A Yui; S Endres; D W Burt; V E Kelley
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

10.  Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis.

Authors:  R P Wuthrich; A M Jevnikar; F Takei; L H Glimcher; V E Kelley
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

View more
  8 in total

1.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

2.  Pharmacokinetic and pharmacodynamic relationship of AMG 811, an anti-IFN-γ IgG1 monoclonal antibody, in patients with systemic lupus erythematosus.

Authors:  Ping Chen; Thuy Vu; Adimoolam Narayanan; Winnie Sohn; Jin Wang; Michael Boedigheimer; Andrew A Welcher; Barbara Sullivan; David A Martin; Juan Jose Perez Ruixo; Peiming Ma
Journal:  Pharm Res       Date:  2014-09-12       Impact factor: 4.200

3.  Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.

Authors:  Gloria Yiu; Tue K Rasmussen; Bahareh Ajami; David J Haddon; Alvina D Chu; Stephanie Tangsombatvisit; Winston A Haynes; Vivian Diep; Larry Steinman; James Faix; Paul J Utz
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

Review 4.  Mechanisms of tissue injury in lupus nephritis.

Authors:  Tamara K Nowling; Gary S Gilkeson
Journal:  Arthritis Res Ther       Date:  2011-12-21       Impact factor: 5.156

5.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.

Authors:  A N Theofilopoulos; S Koundouris; D H Kono; B R Lawson
Journal:  Arthritis Res       Date:  2001-02-14

6.  Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr mice.

Authors:  Fumitaka Shiozawa; Tsuyoshi Kasama; Nobuyuki Yajima; Tsuyoshi Odai; Takeo Isozaki; Mizuho Matsunawa; Yoshiyuki Yoda; Masao Negishi; Hirotsugu Ide; Mitsuru Adachi
Journal:  Arthritis Res Ther       Date:  2003-11-19       Impact factor: 5.156

7.  Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model.

Authors:  Jatin Sharma; Teresa D Collins; Tracoyia Roach; Shiwangi Mishra; Brandon K Lam; Zaynab Sidi Mohamed; Antia E Veal; Timothy B Polk; Amari Jones; Caleb Cornaby; Mohammed I Haider; Leilani Zeumer-Spataro; Howard M Johnson; Laurence M Morel; Joseph Larkin
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.996

8.  Deletion of microRNA-183-96-182 Cluster in Lymphocytes Suppresses Anti-DsDNA Autoantibody Production and IgG Deposition in the Kidneys in C57BL/6-Faslpr/lpr Mice.

Authors:  Zhuang Wang; Bettina Heid; Ran Lu; Mohit Sachdeva; Michael R Edwards; JingJing Ren; Thomas E Cecere; Deena Khan; Taschua Jeboda; David G Kirsch; Christopher M Reilly; Rujuan Dai; S Ansar Ahmed
Journal:  Front Genet       Date:  2022-07-07       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.